Category: News

Unbelievably, the summer has already drawn to a close. This means that the 15 undergraduate students chosen to undertake a BioCanRx-funded research internship in cancer immunotherapeutics have departed as well. We are so proud of the knowledge and growth our summer students have gained and we wish them all the best.   Curious what these… Read more »

By Dr. Barbara Vanderhyden, David Cook and Pascale Robineau-Charette   Most scientists recognize the need to talk to the media when they call. But at times, especially during periods when public funding for research is constrained, there is growing attention to the need to be more proactive in sharing your research with the public. The… Read more »

By: Heather Blumenthal   If you remember the movie The Graduate, you’ll remember Dustin Hoffman being told that the next big thing is plastics.   Today, the next big thing in immunotherapy is combination therapy – combining a checkpoint inhibitor, which stops cancer cells from blocking attacks from the immune system, and a therapy that,… Read more »

June is Immunotherapy Month and BioCanRx participated in a number of events including:   “It’s in you to fight cancer”   BioCanRx was honoured to take part in the Canadian Cancer Survivor Network’s breakfast, “It’s in you to fight cancer,” held on Parliament Hill for Immunotherapy Month. Dr. Kelley Parato, BioCanRx’s Director of Scientific Affairs,… Read more »

  Just four months to go until the 2018 Summit for Cancer Immunotherapy (Summit4CI) taking place October 27 to 30, in Banff, Alberta!   This 3rd annual scientific meeting of BioCanRx will bring together more than 300 leading scientists, clinicians, students and economists with representatives from industry, patient groups, charities and government. The conference will… Read more »

At BioCanRx, we are incredibly proud of our HQP and their dedication to cancer immunotherapy research. Whether they are working on viruses in the lab or examining the socioeconomic barriers to adopting certain treatments in Canada, each one plays a unique role in strengthening our network and expertise in immunotherapy.   BioCanRx is invested in… Read more »

By Linda Eagen and Kathy Matuszewska   Patient and public awareness, interest, and engagement as care and research partners is increasingly a key component of cancer care innovation.   In recent years, the traditional clinical approach to cancer care whereby healthcare professionals control the treatment plan is being challenged to include patients as partners in… Read more »

By Heather Blumenthal In healthcare, as in so much else in life, it comes down to one key question: Who is going to pay?   In Canada, it’s complicated. The payer can be the government, but it can also be private health insurance or even users, out of their own pocket, sometimes travelling to other… Read more »

  BioCanRx v2.0 Setting the Stage for Network Renewal   *CALL FOR EXPRESSIONS OF INTEREST: BioCanRx, Canada’s Immunotherapy Network, is pleased to announce a Call for Expressions of Interest to bring forward in our Cycle II application in June 2019 to the federal government’s Networks of Centres of Excellence (NCE) Program. BioCanRx was first awarded… Read more »